Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-72,752,914
-
Total reported value, excl. options
-
$0
-
Value change
-
-$1,415,128,694
-
Number of sells
-
-177
Significant Holders of IMPAX LABORATORIES INC - COM (IPXL) as of Q2 2018
180 filings reported holding IPXL - IMPAX LABORATORIES INC - COM as of Q2 2018.
IMPAX LABORATORIES INC - COM (IPXL) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
.
Largest 10 shareholders include Aperio Group, LLC (0 shares), Lenox Wealth Advisors, LLC (0 shares), LS Investment Advisors, LLC (0 shares), Front Row Advisors LLC (0 shares), SEI INVESTMENTS CO (0 shares), Zurcher Kantonalbank (Zurich Cantonalbank) (0 shares), Bank of New York Mellon Corp (0 shares), MACKAY SHIELDS LLC (0 shares), ARGENT CAPITAL MANAGEMENT LLC (0 shares), and PNC Financial Services Group, Inc. (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.